Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome.

Malinen E, Krogius-Kurikka L, Lyra A, Nikkilä J, Jääskeläinen A, Rinttilä T, Vilpponen-Salmela T, von Wright AJ, Palva A.

World J Gastroenterol. 2010 Sep 28;16(36):4532-40.

2.

Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.

Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, Mättö J, Mäkelä L, Palva A.

World J Gastroenterol. 2009 Dec 21;15(47):5936-45.

3.

Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.

Shukla R, Ghoshal U, Dhole TN, Ghoshal UC.

Dig Dis Sci. 2015 Oct;60(10):2953-62. doi: 10.1007/s10620-015-3607-y. Epub 2015 Mar 18.

PMID:
25784074
4.

Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.

Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A.

Am J Gastroenterol. 2005 Feb;100(2):373-82.

PMID:
15667495
5.

Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes.

Lyra A, Krogius-Kurikka L, Nikkilä J, Malinen E, Kajander K, Kurikka K, Korpela R, Palva A.

BMC Gastroenterol. 2010 Sep 19;10:110. doi: 10.1186/1471-230X-10-110.

6.

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.

Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A.

Gastroenterology. 2007 Jul;133(1):24-33. Epub 2007 Apr 14.

PMID:
17631127
7.

Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria.

Maukonen J, Satokari R, Mättö J, Söderlund H, Mattila-Sandholm T, Saarela M.

J Med Microbiol. 2006 May;55(Pt 5):625-33.

PMID:
16585652
8.

Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome.

Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S.

Neurogastroenterol Motil. 2010 May;22(5):512-9, e114-5. doi: 10.1111/j.1365-2982.2009.01427.x. Epub 2009 Nov 10.

9.

Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.

Rajilić-Stojanović M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM.

Gastroenterology. 2011 Nov;141(5):1792-801. doi: 10.1053/j.gastro.2011.07.043. Epub 2011 Aug 5.

PMID:
21820992
10.

Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.

Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Mäkivuokko H, Kajander K, Palva A.

BMC Gastroenterol. 2009 Dec 17;9:95. doi: 10.1186/1471-230X-9-95.

11.

Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome.

Rigsbee L, Agans R, Shankar V, Kenche H, Khamis HJ, Michail S, Paliy O.

Am J Gastroenterol. 2012 Nov;107(11):1740-51.

PMID:
22986438
12.

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.

J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1.

PMID:
22157240
13.

Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.

Chassard C, Dapoigny M, Scott KP, Crouzet L, Del'homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, Dubray C, Flint HJ, Bernalier-Donadille A.

Aliment Pharmacol Ther. 2012 Apr;35(7):828-38. doi: 10.1111/j.1365-2036.2012.05007.x. Epub 2012 Feb 8.

14.

Microbial community and metabolomic comparison of irritable bowel syndrome faeces.

Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH.

J Med Microbiol. 2011 Jun;60(Pt 6):817-27. doi: 10.1099/jmm.0.028126-0. Epub 2011 Feb 17.

15.

Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.

Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A, Petrosino JF, Highlander S, Gibbs R, Lynch SV, Shulman RJ, Versalovic J.

Gastroenterology. 2011 Nov;141(5):1782-91. doi: 10.1053/j.gastro.2011.06.072. Epub 2011 Jul 8.

16.

Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating.

Ringel-Kulka T, Benson AK, Carroll IM, Kim J, Legge RM, Ringel Y.

Am J Physiol Gastrointest Liver Physiol. 2016 Mar 15;310(6):G417-26. doi: 10.1152/ajpgi.00044.2015. Epub 2015 Dec 23.

PMID:
26702134
17.

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.

Jeffery IB, O'Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EM, Simrén M.

Gut. 2012 Jul;61(7):997-1006. doi: 10.1136/gutjnl-2011-301501. Epub 2011 Dec 16.

PMID:
22180058
18.

A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR.

Dig Dis Sci. 2010 Feb;55(2):392-7. doi: 10.1007/s10620-009-0934-x. Epub 2009 Aug 20.

PMID:
19693670
19.

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

Mättö J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M.

FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):213-22.

20.

Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives.

Salonen A, de Vos WM, Palva A.

Microbiology. 2010 Nov;156(Pt 11):3205-15. doi: 10.1099/mic.0.043257-0. Epub 2010 Aug 12. Review.

PMID:
20705664
Items per page

Supplemental Content

Write to the Help Desk